UBE2C Drives Human Cervical Cancer Progression and Is Positively Modulated by mTOR

Cervical cancer is a common gynecological malignancy, accounting for 10% of all gynecological cancers. Recently, targeted therapy for cervical cancer has shown unprecedented advantages. Several studies have shown that ubiquitin conjugating enzyme E2 (UBE2C) is highly expressed in a series of tumors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, An-Jen, Li, Chia-Jung, Tsui, Kuan-Hao, Chang, Chung, Chang, Yuan-chin Ivan, Chen, Li-Wen, Chang, Tsung-Hsien, Sheu, Jim Jinn-Chyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823929/
https://www.ncbi.nlm.nih.gov/pubmed/33396624
http://dx.doi.org/10.3390/biom11010037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823929/
https://www.ncbi.nlm.nih.gov/pubmed/33396624
http://dx.doi.org/10.3390/biom11010037

Ejemplares similares